A cost-effectiveness analysis of Onabotulinumtoxin A as first-line treatment for overactive bladder
2018 ◽
Vol 29
(8)
◽
pp. 1213-1219
◽
2018 ◽
Vol 73
(11)
◽
pp. 629-630
2017 ◽
Vol 20
(6)
◽
pp. 574-584
◽
2020 ◽
Vol 18
(1)
◽